Found 94 matching trials
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T Β± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation PHASE2 The purpose of this trial is to confirm the safety and efficacy of high-dos...
Show More Location
Rush University Medical Center
Learn More & Join Trial
Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma PHASE1 The purpose of this study is to evaluate the safety and efficacy of Bendamu...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant PHASE1 This phase I trial studies the best dose and how well bendamustine works wi...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) PHASE1 Based on the further need to improve progression-free survival (PFS) and ov...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Pembrolizumab in Combination With R-ICE Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This is an open-label, multicentre, randomised phase II trial in relapsed o...
Show More Status
Active Not Recruiting
Location
The Beatson West of Scotland Cancer Centre
Learn More & Join Trial
The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd) PHASE3 Study design: Randomised, controlled, multi-centre, open-label, phase III t...
Show More Location
Aberdeen Royal Infirmary
Learn More & Join Trial
Integrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL NA This study aims to investigate a novel therapeutic strategy of integrated r...
Show More Location
the First Affiliated Hospital of Soochow University
Learn More & Join Trial
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction, Followed by Risk- and Response-Adapted Consolidation and Maintenance Therapy, in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma PHASE3 The purpose of the study is to determine the best treatment approach based ...
Show More Location
Beth Israel Deaconess Medical Center (BIDMC)
Learn More & Join Trial
Impact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden N/A This retrospective observational cohort study aims to describe the impact o...
Show More Location
Uppsala Universitet
Learn More & Join Trial